Nicholas J. Virca

Overview

Nicholas J. Virca received an average of $217K in total compensation, including $169K in salary, at HedgePath Pharmaceuticals between 2015 and 2016.

Source: SEC filing on November 13, 2017.

Related executives

We found five more executives who work or worked at HedgePath Pharmaceuticals.

Garrison Hasara

HedgePath Pharmaceuticals

Chief Financial Officer

Richard Freer

HedgePath Pharmaceuticals

Chief Operating Officer

Paul D'Sylva

HedgePath Pharmaceuticals

Chief Executive Officer

Robert Harris

HedgePath Pharmaceuticals

President

Thomas Reynolds

HedgePath Pharmaceuticals

Senior Vice President

You may also like